The table below shows RHYTHM PHARMACEUTICALS, INC.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$44.19M
-$40.35M
-$40.74M
-$36.43M
-$53.63M
-$33.53M
Capital expenditure
-
-
-
$47.00K
$127.00K
$12.00K
Investing cash flow
$57.05M
$24.81M
$30.05M
$18.46M
$72.52M
-$145.71M
Dividends paid
-
-
-
-
RYTM operating cash flow (10-K history)
RHYTHM PHARMACEUTICALS, INC. reported operating cash flow of -$115.67M for fiscal year 2025. That is down 1.6% from -$113.88M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$23.22M (FY 2016) to -$115.67M. Figures come from the company's audited annual reports as filed with the SEC.
